Minority Investment
August 2011
NextDocs, a SharePoint based life sciences document compliance solutions provider, has received a minority investment from Openview, a Boston-based venture capital firm.
- Nextdocs counts over 100 life sciences companies as clients, including 5 of the top 10 pharmaceutical companies and two of the largest CROs
- NextDocs is already an Inc. 500 and Deloitte Fast 50 company
About NextDocs
NextDocs is the global leader in providing Microsoft SharePoint-based compliance solutions to life sciences organizations. It enables businesses in regulated industries to achieve compliance with FDA and other agencies while automating processes, improving efficiency and dramatically reducing costs. NextDocs customers include Pharmaceutical companies, Bio-Techs, Medical Device companies and CROs.
About OpenView Venture Partners
OpenView Venture Partners is an expansion stage venture capital fund with a focus on high-growth software, Internet, and technology-enabled companies. Through its staff of seasoned operating executives, who collectively bring several decades of technology and management experience to the firm, OpenView is able to help portfolio companies with quickly ramping up Product, Go-To-Market, and Organizational and Operational functions to best practice levels. The firm was founded in 2006 and has a total capital under management of approximately $240 million. OpenView Venture Partners is based in Boston and invests on a worldwide basis.
Client Highlights
- 2 Transactions
- 5 Years of Partnership
Transaction Details
-
SectorsVerticalized Platforms
-
ServiceCapital Raise
-
OwnershipFounder-Owned
-
Practices
Sponsor Coverage
Sponsor Coverage
“What truly differentiates NextDocs is the breadth and depth of its solution, the exceptional list of large and mid-market customers, and extraordinary operational execution. The vision for NextDocs is to become the leading solution provider focused on addressing a wide range of compliance-centric needs in regulated industries.”